292 related articles for article (PubMed ID: 28366633)
1. Wnt signaling promotes androgen-independent prostate cancer cell proliferation through up-regulation of the hippo pathway effector YAP.
Seo WI; Park S; Gwak J; Ju BG; Chung JI; Kang PM; Oh S
Biochem Biophys Res Commun; 2017 May; 486(4):1034-1039. PubMed ID: 28366633
[TBL] [Abstract][Full Text] [Related]
2. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.
Zhang L; Yang S; Chen X; Stauffer S; Yu F; Lele SM; Fu K; Datta K; Palermo N; Chen Y; Dong J
Mol Cell Biol; 2015 Apr; 35(8):1350-62. PubMed ID: 25645929
[TBL] [Abstract][Full Text] [Related]
3. FFAR1-and FFAR4-dependent activation of Hippo pathway mediates DHA-induced apoptosis of androgen-independent prostate cancer cells.
Wang J; Hong Y; Shao S; Zhang K; Hong W
Biochem Biophys Res Commun; 2018 Nov; 506(3):590-596. PubMed ID: 30366669
[TBL] [Abstract][Full Text] [Related]
4. Wnt3a growth factor induces androgen receptor-mediated transcription and enhances cell growth in human prostate cancer cells.
Verras M; Brown J; Li X; Nusse R; Sun Z
Cancer Res; 2004 Dec; 64(24):8860-6. PubMed ID: 15604245
[TBL] [Abstract][Full Text] [Related]
5. Androgen attenuates the inactivating phospho-Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity.
Cinar B; Al-Mathkour MM; Khan SA; Moreno CS
J Biol Chem; 2020 Jun; 295(25):8550-8559. PubMed ID: 32376689
[TBL] [Abstract][Full Text] [Related]
6. The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.
Schweizer L; Rizzo CA; Spires TE; Platero JS; Wu Q; Lin TA; Gottardis MM; Attar RM
BMC Cell Biol; 2008 Jan; 9():4. PubMed ID: 18218096
[TBL] [Abstract][Full Text] [Related]
7. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
[TBL] [Abstract][Full Text] [Related]
8. Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway.
Zeng H; Ortiz A; Shen PF; Cheng CJ; Lee YC; Yu G; Lin SC; Creighton CJ; Yu-Lee LY; Lin SH
Oncotarget; 2017 Feb; 8(6):10145-10160. PubMed ID: 28052036
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of YAP inhibits growth in Hep-2 laryngeal cancer cells via epithelial-mesenchymal transition and the Wnt/β-catenin pathway.
Tang X; Sun Y; Wan G; Sun J; Sun J; Pan C
BMC Cancer; 2019 Jul; 19(1):654. PubMed ID: 31269911
[TBL] [Abstract][Full Text] [Related]
10. The Hippo Pathway in Prostate Cancer.
Salem O; Hansen CG
Cells; 2019 Apr; 8(4):. PubMed ID: 31018586
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
[TBL] [Abstract][Full Text] [Related]
12. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
Dulinska-Litewka J; McCubrey JA; Laidler P
Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
[TBL] [Abstract][Full Text] [Related]
13. Wnt activated β-catenin and YAP proteins enhance the expression of non-coding RNA component of RNase MRP in colon cancer cells.
Park J; Jeong S
Oncotarget; 2015 Oct; 6(33):34658-68. PubMed ID: 26415221
[TBL] [Abstract][Full Text] [Related]
14. YAP balances the osteogenic and adipogenic differentiation of hPDLSCs in vitro partly through the Wnt/β-catenin signaling pathway.
Jia L; Zhang Y; Ji Y; Xiong Y; Zhang W; Wen Y; Xu X
Biochem Biophys Res Commun; 2019 Oct; 518(1):154-160. PubMed ID: 31421821
[TBL] [Abstract][Full Text] [Related]
15. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer.
Terry S; Yang X; Chen MW; Vacherot F; Buttyan R
J Cell Biochem; 2006 Oct; 99(2):402-10. PubMed ID: 16741972
[TBL] [Abstract][Full Text] [Related]
16. Morin impedes Yap nuclear translocation and fosters apoptosis through suppression of Wnt/β-catenin and NF-κB signaling in Mst1 overexpressed HepG2 cells.
Perumal N; Perumal M; Kannan A; Subramani K; Halagowder D; Sivasithamparam N
Exp Cell Res; 2017 Jun; 355(2):124-141. PubMed ID: 28366538
[TBL] [Abstract][Full Text] [Related]
17. The beta-catenin binding protein ICAT modulates androgen receptor activity.
Zhuo M; Zhu C; Sun J; Weis WI; Sun Z
Mol Endocrinol; 2011 Oct; 25(10):1677-88. PubMed ID: 21885566
[TBL] [Abstract][Full Text] [Related]
18. SETD7 Controls Intestinal Regeneration and Tumorigenesis by Regulating Wnt/β-Catenin and Hippo/YAP Signaling.
Oudhoff MJ; Braam MJS; Freeman SA; Wong D; Rattray DG; Wang J; Antignano F; Snyder K; Refaeli I; Hughes MR; McNagny KM; Gold MR; Arrowsmith CH; Sato T; Rossi FMV; Tatlock JH; Owen DR; Brown PJ; Zaph C
Dev Cell; 2016 Apr; 37(1):47-57. PubMed ID: 27046831
[TBL] [Abstract][Full Text] [Related]
19. GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway.
Wang Z; Ran X; Qian S; Hou H; Dong M; Wu S; Ding M; Zhang Y; Zhang X; Zhang M; Chen Q
Arch Biochem Biophys; 2021 Oct; 710():108998. PubMed ID: 34280359
[TBL] [Abstract][Full Text] [Related]
20. Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer.
Kawano Y; Diez S; Uysal-Onganer P; Darrington RS; Waxman J; Kypta RM
Br J Cancer; 2009 Apr; 100(7):1165-74. PubMed ID: 19277043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]